(HealthDay)—One year of adjuvant olaparib should be offered to patients with high-risk early-stage human epidermal growth factor receptor 2 (HER2)-negative
Read more
Home »
Immune interference: Why even ‘updated’ vaccines could struggle to keep up with emerging coronavirus strains
Despite the success and optimism of the new COVID-19 vaccination campaigns being rolled out worldwide, the emergence of new viral
Read more
Treatment for diverticulitis: Updated ASCRS guidelines published
Reflecting research-driven changes in clinical practice, a revised set of evidence-based recommendations for the medical and surgical treatment of left-sided
Read more